Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effect of praziquantel on the free-living stages ofSchistosoma mansoni


The effect of the new schistosomicide praziquantel (2-cyclohexyl-carbonyl-1,2,3,6,7,11b-hexahydro-2H-pyrazino[2,1a]isoquinolin-4-one) on the miracidia and cercariae ofSchistosoma mansoni was investigated.

In vivo praziquantel inhibits hatching of miracidia for 24 h after administration of 500 mg/kg to infected mice. In vitro a concentration of 10 μg/ml inhibits subsequent hatching in drug-free water. Free swimming miracidia are rapidly killed by 1 μg/ml. Even 0.01 μg/ml is still partially effective.

In a solution of 0.03 μg/ml cercariae lose their ability to swim within 10 min. This effect is reversible in drug-free water. Morphological damage to cercariae incubated in 0.1 μg/ml is clearly evident. However, cercariae are fully infective when given subcutaneously to mice after a 3-h incubation period. Incubation in 1 μg/ml reduces the infection rate by 80%. A 2-h incubation in 0.1 μg/ml almost completely inhibits the percutaneous infection through the abdominal skin. The number of cercariae that develop to schistosomules is reduced by more than 90%. After a 2-h incubation in a concentration of 0.01 μg/ml the swimming ability of cercariae is impaired in such a way that the number of cercariae penetrating in the tail immersion test and developing to schistosomules is reduced by half.

Praziquantel is a more potent protective agent than the molluscicides copper sulphate, sodium pentachlorophenate and Bayluscide® or cadmium and zinc ions.


Es wurde der Einfluß des neuen Schistosomenmittels Praziquantel (2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-2H-pyrazino[2,1 a]isochinolin-4-on) auf die Miracidien und Cercarien vonSchistosoma mansoni untersucht.

In vivo verhindert Praziquatel das Schlüpfen von Miracidien aus Eiern für 24 h nach einer Behandlung infizierter Mäuse mit 500 mg/kg. Nach Inkubation von Eiern in 10 μg/ml schlüpfen anschließend keine Miracidien in präparatfreiem Wasser. Frei schwimmende Miracidien werden durch 1 μg/ml schnell abgetötet und noch 0,01 μg/ml haben eine deutliche Wirkung.

Cercarien werden in vitro durch 0,03 μg/ml innerhalb von 10 min schwimmunfähig. Dieser Effekt ist in präparatfreiem Wasser reversibel. Nach 3stündiger Vorbehandlung in 0,1 μg/ml sind die Cercarien deutlich morphologisch geschädigt. Trotzdem sind sie noch normal entwicklungsfähig, wenn sie Mäusen subcutan injiziert werden. Nach Inkubation in 1 μg/ml ist der Infektionserfolg allerdings um 80% reduziert. Nach nur 2stündiger Inkubation in 0,1 μg/ml ist die Zahl der Cercarien, die sich nach percutaner Infektion durch die Bauchhaut der Maus zu Schistosomulae entwickelt, um mehr als 90% reduziert. Nach 2stündiger Inkubation in nur 0,01 μg/ml ist das Schwimmvermögen der Cercarien so beeinträchtigt, daß sich nach percutaner Schwanzinfektion nur noch halb so viele zu Schistosomulae entwickeln wie in der Kontrolle.

Praziquantel ist in seiner infektionsverhindernden Wirkung den Molluskiziden Kupfersulfat, Pentachlorphenolnatrium und Bayluscid® sowie auch Cadmium- und Zinkionen überlegen.

This is a preview of subscription content, log in to check access.


  1. Andrews, P.: Pharmacokinetic studies with Praziquantel in animals using a biological assay. Vet. Med. Nachr., 154–165 (1976)

  2. Asch, H.L., M.H. Dresden:Schistosoma mansoni: effects of zinc on cercarial and schistosomule viability. J. Parasitol.,63, 80–86 (1977)

  3. Duvall, R.H., DeWitt, W.B.: An improved perfusion technique for recovering adult schistosomes from laboratory animals. Amer. J. Trop. Med. Hyg.,16, 483–486 (1967)

  4. Esham, L.P.: Toxicity of cadmium toSchistosoma mansoni (Sambon, 1907) cercariae: Effects on vitality and development ability in white mice. Diss. Abstr. Intern.,35, 4282 (1975)

  5. Ghandour, A.M., Webbe, G.: The effect of sublethal concentrations of the molluscicide niclosamide on the infectivity ofSchistosoma cercariae. J. Helminthol.,49, 245–250 (1975)

  6. Gönnert, R.: Results of laboratory and field trials with the molluscicide Bayer 73. Bull. WHO25, 483–501 (1961)

  7. Gönnert, R., Andrews, P.: Praziquantel, a new broad-spectrum, antischistosomal agent. Z. Parasitenkd.,52, 129–150 (1977)

  8. James, C., Webbe, G., Nelson, G.S.: The susceptibility to praziquantel ofSchistosoma haematobium in the baboon (Papio anubis) and ofS. japonicum in the vervet monkey (Cercopithecus aethiops) z. Parasitenkd.,52, 179–194 (1977)

  9. Lagrange, E.: Une méthode simple d'essai des anti-bilharziens in vitro. C.R. Soc. Biol. (Paris),154, 1498–1499 (1960)

  10. Lambert, C.R., Stauffer, P.: Chemotherapy of experimentalSchistosoma mansoni infections with a nitro-thiazole derivative, Ciba 32.644 Ba. Ann. trop. Med.,58, 292–303 (1964)

  11. Laufer, E.W.: Some observations onSchistosoma haematobium, Med. Proc.16, 103–107 (1970)

  12. Leopold, G., Diekmann, H., Nowak, H., Patzschke, K.: Pharmakokinetik von Praziquantel. Tropenmed. Parasitol.,28, 275 (1977)

  13. Leopold, G., Diekmann, H.W., Ungethüm, W., Nowak, H.: Phase I: Clinical pharmacology of praziquantel, a new drug against Schistosomiasis and Cestodiasis. II. Pharmacokinetics of the unchanged substance. Eur. J. Clin. Pharmacol., (in press, 1978)

  14. Mecham, J.A., Holliman, R.B.: Toxicity of zinc toSchistosoma mansoni cercariae in a chemically defined water medium. Hydrobiologia,46, 391–404 (1975)

  15. Mousa, A.H., Yousif, F., El-Ghayeb, F.M.: Studies on low concentrations of molluscicides. II. Effect of low concentration of molluscicides on the survival and infectivity ofSchistosoma mansoni cercairae. Bull. Zool. Soc. Egypt.,23, 65–73 (1970/71)

  16. Olivier, L.J.: Infectivity ofSchistosoma mansoni cercariae. Am. J. trop. med. Hyg.,15, 882–885 (1966)

  17. Pellegrino, J.: Protection against human schistosome cercariae. Exp. Parasitol.,21, 112–131 (1967)

  18. Pellegrino, J., Maria, M. de: In vitro cercaricidal activity of schistosomicides. J. Parasitol.,52, 617 (1966)

  19. Pellegrino, J., Lima-Costa, F.F., Carlos, M.A., Mello, R.T.: Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino derivative, on mice, hamsters and Cebus monkeys. Z. Parastienkd.52, 151–168 (1977)

  20. Pellegrino, J., Valle, C.: Influência do geotropismo negativo da cerária, doSchistosoma mansoni sobre a infeçcão do camundongo pela cauda. Rev. Inst. Med. Hyg. trop. Sao Paulo16, 179–181 (1974)

  21. Perez, H., Clegg, J.A., Smithers, S.R.: Acquired immunity toSchistsosoma mansoni in the rat: measurement of immunity by the lung recovery technique Parasitology,69, 349–359 (1974)

  22. Steiner, K., Garbe, A., Diekmann, H.W., Nowak, H.: The fate of praziquantel in the organism. 1. Pharmacokinetics in animals. Eur. J. Drug Metab. Pharmacokin.,2, 85–95 (1976)

  23. Webbe, G., James, C.: A comparison of the susceptibility to praziquantel ofSchistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum andS. mattheei in hamsters. Z. Parasitenkd.,52, 169–177 (1977)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Andrews, P. Effect of praziquantel on the free-living stages ofSchistosoma mansoni . Z. Parasitenkd. 56, 99–106 (1978).

Download citation


  • Praziquantel
  • Copper Sulphate
  • Swimming Ability
  • Free Swimming
  • Tail Immersion